KCAS Bioanalytical Services
Jeff Goddard joined KCAS Bioanalytical and Biomarker Services in August 2021 as Senior Vice President of Corporate Development. In this role, Jeff leads efforts to grow through acquisition, strategic partnerships and service expansions.
Jeff brings over two decades of relevant industry experience to KCAS, ranging from start-ups to Fortune 500 firms. Previous to joining KCAS, Jeff served as CEO of AIT Bioscience, where he led the company’s growth and successful sale to Nexelis in 2020. He remained with Nexelis as SVP, Business Development and a member of the senior leadership team. Prior to AIT Bioscience, Jeff led global business development for EPL Archives, a leading biorepository services provider. Under Jeff’s leadership, EPL Archives tripled its revenue, expanded into Europe, and successfully sold to VWR International in 2017. Prior to EPL Archives, Jeff held global commercial leadership positions at BioStorage Technologies (now Brooks Life Science), Gene Logic, Xceleron (now part of Pharmaron) and BASi (now Inotiv).
Jeff received his Bachelor of Science degree in Chemical Engineering from the University of Notre Dame and a Master of Business Administration degree with concentrations in International Business and Management of Innovation & Technology from George Washington University.
This person is not in any teams
This person is not in any offices
KCAS Bioanalytical Services
1 followers
KCAS Bioanalytical and Biomarker Services, an Integris BioServices, LLC Company is a rapidly growing company that provides comprehensive GLP / GCP compliant development services from early discovery support through product registration and beyond. KCAS provides a truly differentiated approach as one of only a select few CROs offering both large and small molecule development with extensive capabilities and expertise to its clients who are looking for both scientific expertise and excellent customer service.